Gherlinzoni F - Search Results

1

Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma.

Zinzani PL, Bendandi M, Magagnoli M, Gherlinzoni F, Merla E, Tura S. Zinzani PL, et al. Among authors: gherlinzoni f. Ann Oncol. 1997 Apr;8(4):379-83. doi: 10.1023/a:1008228709612. Ann Oncol. 1997. PMID: 9209669 Free article. Clinical Trial.

2

Massive mediastinal involvement in stage I-II Hodgkin's disease: response to combined modality treatment.

Zinzani PL, Mazza P, Gherlinzoni F, Bocchia M, Fiacchini M, Bendandi M, Barbieri E, Frezza G, Neri S, Aitini E, et al. Zinzani PL, et al. Among authors: gherlinzoni f. Leuk Lymphoma. 1992 Sep;8(1-2):81-5. doi: 10.3109/10428199209049821. Leuk Lymphoma. 1992. PMID: 1493474

3

MN (N = Novantrone) COP-B therapy on high and intermediate grade non-Hodgkin's lymphoma: an alternative to MA (A = adriamycin) COP-B?

Mazza P, Bocchia M, Zanchini R, Gherlinzoni F, Zinzani PL, Pileri S, Tura S. Mazza P, et al. Among authors: gherlinzoni f. Haematologica. 1991 Jan-Feb;76(1):47-52. Haematologica. 1991. PMID: 1711505

4

MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.

Tura S, Mandelli F, Mazza P, Pileri S, Gherlinzoni F, Bocchia M, Zinzani PL, Fiacchini M, Martelli M, Papa G, et al. Tura S, et al. Among authors: gherlinzoni f. Leukemia. 1991;5 Suppl 1:74-8. Leukemia. 1991. PMID: 1716338 Clinical Trial.

5

Stage I high-grade non-Hodgkin's lymphomas: a retrospective analysis.

Gherlinzoni F, Mazza P, Bocchia M, Zinzani PL, Fiacchini M, Zanchini R, Pileri S, Tura S. Gherlinzoni F, et al. Haematologica. 1991 Jan-Feb;76(1):38-42. Haematologica. 1991. PMID: 2055559

6

CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report.

Zinzani PL, Mazza P, Gherlinzoni F, Zanchini R, Bocchia M, Aitini E, Cavazzini G, Amurri B, Gobbi M, Tura S. Zinzani PL, et al. Among authors: gherlinzoni f. Tumori. 1990 Dec 31;76(6):533-6. doi: 10.1177/030089169007600603. Tumori. 1990. PMID: 2284688 Clinical Trial.

7

Phase II cooperative study with a new alkylating drug, PTT-119, in the treatment of non-Hodgkin's lymphomas.

Gherlinzoni F, Mazza P, Zinzani PL, Tura S, Lanza F, Castoldi G, Bellesi G, Rossi Ferrini PL, Mangoni L, Rizzoli V, et al. Gherlinzoni F, et al. Blut. 1990 Mar;60(3):172-6. doi: 10.1007/BF01720271. Blut. 1990. PMID: 2317568

8

Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas.

Tura S, Mazza P, Gherlinzoni F, Zinzani PL, Poletti G, Visani G, Lemoli RM, Cavo M, Galieni P, Tassi C, et al. Tura S, et al. Among authors: gherlinzoni f. Cancer Chemother Pharmacol. 1989;23(2):123-5. doi: 10.1007/BF00273532. Cancer Chemother Pharmacol. 1989. PMID: 2910510

9

VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly.

Zinzani PL, Bendandi M, Gherlinzoni F, Mazza P, Salvucci M, Aitini E, Miggiano MC, Gozzetti A, Tura S. Zinzani PL, et al. Among authors: gherlinzoni f. Haematologica. 1993 Nov-Dec;78(6):378-82. Haematologica. 1993. PMID: 7513674

10

Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease.

Zinzani PL, Barbieri E, Visani G, Gherlinzoni F, Perini F, Neri S, Bendandi M, Ammendolia I, Salvucci M, Babini L, et al. Zinzani PL, et al. Among authors: gherlinzoni f. Haematologica. 1994 Nov-Dec;79(6):508-12. Haematologica. 1994. PMID: 7534744 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters